SUPREME COURT SEEKS ADMINISTRATION'S OPINION ON IDE APPROVAL PREEMPTION OVER TORT CLAIMS; IOLAB PETITION QUESTIONS APPLICABILITY OF MEDTRONIC V. LOHR
This article was originally published in The Gray Sheet
The Administration is expected to file in 60-90 days its opinion on whether FDA's Investigational Device Exemption regulation preempts state tort claims in response to a case before the U.S. Supreme Court.
You may also be interested in...
The U.S. Supreme Court is considering whether to hear a potentially far-reaching case on whether patients injured by PMA-approved devices can sue manufacturers under state laws
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.